Skip Navigation



European Heart Journal Advance Access published online on April 26, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi285
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
26/18/1903    most recent
ehi285v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lenk, K.
Right arrow Articles by Hambrecht, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lenk, K.
Right arrow Articles by Hambrecht, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

European Heart Journal © The European Society of Cardiology 2005; all rights reserved
Received August 17, 2004
Revised March 8, 2005
Accepted March 24, 2005

Clinical research

Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia

Karsten Lenk 1, Volker Adams 1, Philipp Lurz 1, Sandra Erbs 1, A. Linke 1, Stephan Gielen 1, Andrej Schmidt 2, Dierck Scheinert 2, Giancarlo Biamino 2, Frank Emmrich 3, Gerhard Schuler 1, and Rainer Hambrecht 1*

1 Department of Cardiology, University of Leipzig Heart Center, Strümpellstrasse 39, D-04289 Leipzig, Germany
2 Department of Angiology, University of Leipzig Heart Center, Strümpellstrasse 39, D-04289 Leipzig, Germany
3 Institute of Clinical Immunology and Transfusion Medicine, Leipzig, Germany

* To whom correspondence should be addressed.
Rainer Hambrecht, E-mail: hamr{at}medizin.uni-leipzig.de


  Abstract

Aims Despite considerable advances in the therapy of patients with peripheral arterial occlusive disease (PAOD) and critical limb ischaemia (CLI), a substantial number remain, in whom amputation has to be considered the only and final option. Recent evidence from animal models of hind limb ischaemia suggests that neovascularization induced by circulating blood-derived progenitor cells (CPCs) may permit limb salvage. It remains unclear, however, whether an intra-arterial application of autologous CPCs in patients with infrapopliteal PAOD and CLI is safe, feasible, and of potentially beneficial effects.

Methods and results Seven patients with critical PAOD were treated with an intra-arterial infusion of autologous CPCs (39 ± 24x106) isolated from peripheral blood. Pre-interventional stimulation with G-CSF and CPC application was well tolerated. Twelve weeks after CPC administration, the pain-free walking distance increased from 6 ± 13 to 195 ± 196 m. A significant increase in the ankle-brachial index, transcutaneous O2, flow-dependent vasodilation, flow reserve in response to adenosine, and endothelium-dependent vasodilation was observed.

Conclusion These preliminary data in a small series of patients with CLI without surgical or interventional options indicate that CPC application is safe, feasible, and may improve both functional and clinical indices.

Keywords: Circulating progenitor cells; Angiogenesis; Critical limb ischaemia; Neovascularization; Peripheral arterial occlusive disease.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CLIN APPL THROMB HEMOSTHome page
Z. Boda, M. Udvardy, K. Razso, K. Farkas, J. Toth, L. Jambor, Z. Olah, P. Ilonczai, M. Szarvas, J. Kappelmayer, et al.
Stem Cell Therapy: A Promising and Prospective Approach in the Treatment of Patients With Severe Buerger's Disease
Clinical and Applied Thrombosis/Hemostasis, October 1, 2009; 15(5): 552 - 560.
[Abstract] [PDF]

Home page
 ANGIOLOGYHome page
I. Al Mheid and A. A. Quyyumi
Cell Therapy in Peripheral Arterial Disease
Angiology, January 1, 2009; 59(6): 705 - 716.
[Abstract] [PDF]

Home page
 Vasc MedHome page
C Kalka and I. Baumgartner
Gene and stem cell therapy in peripheral arterial occlusive disease
Vascular Medicine, May 1, 2008; 13(2): 157 - 172.
[Abstract] [PDF]

Home page
 JAMAHome page
R. K. Burt, Y. Loh, W. Pearce, N. Beohar, W. G. Barr, R. Craig, Y. Wen, J. A. Rapp, and J. Kessler
Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases
JAMA, February 27, 2008; 299(8): 925 - 936.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Napoli, S. Williams-Ignarro, F. de Nigris, G. de Rosa, L. O. Lerman, B. Farzati, A. Matarazzo, G. Sica, C. Botti, A. Fiore, et al.
Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb
PNAS, November 22, 2005; 102(47): 17202 - 17206.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.